Benefit–Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Benefit–Risk Analysis of Upadacitinib Compared with Adalimumab in the Treatment of Patients with Moderate-to-Severe Rheumatoid Arthritis ; day:23 ; month:11 ; year:2021 ; pages:1-16
Rheumatology and therapy ; (23.11.2021), 1-16
- Creator
-
Conaghan, Philip
Cohen, Stanley
Burmester, Gerd
Mysler, Eduardo
Nash, Peter
Tanaka, Yoshiya
Rigby, William
Patel, Jayeshkumar
Shaw, Tim
Betts, Keith A.
Patel, Pankaj
Liu, Jianzhong
Sun, Rochelle
Fleischmann, Roy
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-021-00399-5
- URN
-
urn:nbn:de:101:1-2022013021085904285940
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Conaghan, Philip
- Cohen, Stanley
- Burmester, Gerd
- Mysler, Eduardo
- Nash, Peter
- Tanaka, Yoshiya
- Rigby, William
- Patel, Jayeshkumar
- Shaw, Tim
- Betts, Keith A.
- Patel, Pankaj
- Liu, Jianzhong
- Sun, Rochelle
- Fleischmann, Roy
- SpringerLink (Online service)